Free Trial

MacroGenics (MGNX) SEC Filings & 10K Form

MacroGenics logo
$1.70 -0.02 (-1.16%)
Closing price 04:00 PM Eastern
Extended Trading
$1.76 +0.05 (+3.24%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent MacroGenics SEC Filings

DateFilerForm TypeView
08/21/2025
3:19 PM
HEIDEN WILLIAM K (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2025
4:01 PM
MacroGenics (Issuer)
Risser Eric Blasius (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2025
4:05 PM
Koenig Scott (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2025
8:24 PM
ARMISTICE CAPITAL, LLC (Filed by)
MacroGenics (Subject)
Form SCHEDULE 13G/A
08/14/2025
3:09 PM
MacroGenics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/17/2025
7:12 PM
BlackRock, Inc. (Filed by)
MacroGenics (Subject)
Form SCHEDULE 13G/A
07/07/2025
6:20 PM
Bellevue Group AG (Filed by)
MacroGenics (Subject)
Form SCHEDULE 13G
06/13/2025
1:50 PM
BB BIOTECH AG (Filed by)
MacroGenics (Subject)
Form SCHEDULE 13G/A
06/10/2025
6:02 AM
MacroGenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
2:31 PM
ARMISTICE CAPITAL, LLC (Filed by)
MacroGenics (Subject)
Form SCHEDULE 13G/A
04/11/2025
3:00 PM
MacroGenics (Filer)
Form DEF 14A
04/11/2025
3:01 PM
MacroGenics (Filer)
Form DEFA14A
03/20/2025
3:05 PM
MacroGenics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2025
3:05 PM
MacroGenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
4:11 PM
MacroGenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2025
3:29 PM
Karrels James (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:31 PM
Bonvini Ezio (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:20 PM
Eck Stephen L. (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:22 PM
MacroGenics (Issuer)
Spitznagel Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:23 PM
MacroGenics (Issuer)
Smith Beth Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:24 PM
MacroGenics (Issuer)
Risser Eric Blasius (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:39 PM
MacroGenics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
02/14/2025
4:52 PM
ARMISTICE CAPITAL, LLC (Filed by)
MacroGenics (Subject)
Form SCHEDULE 13G/A
02/14/2025
1:39 PM
BB BIOTECH AG (Filed by)
MacroGenics (Subject)
Form SCHEDULE 13G/A
02/11/2025
7:30 PM
Karrels James (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
7:33 PM
MacroGenics (Issuer)
Risser Eric Blasius (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
7:33 PM
Bonvini Ezio (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
7:34 PM
Eck Stephen L. (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
7:19 PM
MacroGenics (Issuer)
Peters Jeffrey Stuart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
7:20 PM
MacroGenics (Issuer)
Spitznagel Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
7:28 PM
Koenig Scott (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
7:29 PM
MacroGenics (Issuer)
Smith Beth Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
4:37 PM
MacroGenics (Subject)
WASATCH ADVISORS LP (Filed by)
Form SCHEDULE 13G
01/13/2025
3:39 PM
MacroGenics (Issuer)
Smith Beth Ann (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/21/2024
3:32 PM
MacroGenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
9:44 AM
Frazier Life Sciences Public Fund, L.P. (Filed by)
MacroGenics (Subject)
Form SC 13G
11/08/2024
1:17 PM
BlackRock, Inc. (Filed by)
MacroGenics (Subject)
Form SC 13G/A
11/05/2024
3:02 PM
MacroGenics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
3:03 PM
MacroGenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
6:40 AM
MacroGenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
2:24 PM
BlackRock, Inc. (Filed by)
MacroGenics (Subject)
Form SC 13G/A
Is This Stock the 'Next Nvidia'? (Ad)

'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, and has now reached every AI company in America... including Nvidia, Microsoft, and Meta.tc pixel

Click here to see what this could soon mean for your money.
10/09/2024
3:26 PM
Koenig Scott (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
3:35 PM
Koenig Scott (Reporting)
MacroGenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MGNX) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners